Cargando…

Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility

Nanoparticles (NPs) assumed an important role in the area of drug delivery. Despite the number of studies including NPs are growing over the last years, their side effects on the immune system are often ignored or omitted. One of the most studied polymers in the nano based drug delivery system field...

Descripción completa

Detalles Bibliográficos
Autores principales: Jesus, Sandra, Marques, Ana Patrícia, Duarte, Alana, Soares, Edna, Costa, João Panão, Colaço, Mariana, Schmutz, Mélanie, Som, Claudia, Borchard, Gerrit, Wick, Peter, Borges, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047933/
https://www.ncbi.nlm.nih.gov/pubmed/32154232
http://dx.doi.org/10.3389/fbioe.2020.00100
_version_ 1783502206620663808
author Jesus, Sandra
Marques, Ana Patrícia
Duarte, Alana
Soares, Edna
Costa, João Panão
Colaço, Mariana
Schmutz, Mélanie
Som, Claudia
Borchard, Gerrit
Wick, Peter
Borges, Olga
author_facet Jesus, Sandra
Marques, Ana Patrícia
Duarte, Alana
Soares, Edna
Costa, João Panão
Colaço, Mariana
Schmutz, Mélanie
Som, Claudia
Borchard, Gerrit
Wick, Peter
Borges, Olga
author_sort Jesus, Sandra
collection PubMed
description Nanoparticles (NPs) assumed an important role in the area of drug delivery. Despite the number of studies including NPs are growing over the last years, their side effects on the immune system are often ignored or omitted. One of the most studied polymers in the nano based drug delivery system field is chitosan (Chit). In the scientific literature, although the physicochemical properties [molecular weight (MW) or deacetylation degree (DDA)] of the chitosan, endotoxin contamination and appropriate testing controls are rarely reported, they can strongly influence immunotoxicity results. The present work aimed to study the immunotoxicity of NPs produced with different DDA and MW Chit polymers and to benchmark it against the polymer itself. Chit NPs were prepared based on the ionic gelation of Chit with sodium tripolyphosphate (TPP). This method allowed the production of two different NPs: Chit 80% NPs (80% DDA) and Chit 93% NPs (93% DDA). In general, we found greater reduction in cell viability induced by Chit NPs than the respective Chit polymers when tested in vitro using human peripheral blood monocytes (PBMCs) or RAW 264.7 cell line. In addition, Chit 80% NPs were more cytotoxic for PBMCs, increased reactive oxygen species (ROS) production (above 156 μg/mL) in the RAW 264.7 cell line and interfered with the intrinsic pathway of coagulation (at 1 mg/mL) when compared to Chit 93% NPs. On the other hand, only Chit 93% NPs induced platelet aggregation (at 2 mg/mL). Although Chit NPs and Chit polymers did not stimulate the nitric oxide (NO) production in RAW 264.7 cells, they induced a decrease in lipopolysaccharide (LPS)-induced NO production at all tested concentrations. None of Chit NPs and polymers caused hemolysis, nor induced PBMCs to secrete TNF-α and IL-6 cytokines. From the obtained results we concluded that the DDA of the Chit polymer and the size of Chit NPs influence the in vitro immunotoxicity results. As the NPs are more cytotoxic than the corresponding polymers, one should be careful in the extrapolation of trends from the polymer to the NPs, and in the comparisons among delivery systems prepared with different DDA chitosans.
format Online
Article
Text
id pubmed-7047933
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70479332020-03-09 Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility Jesus, Sandra Marques, Ana Patrícia Duarte, Alana Soares, Edna Costa, João Panão Colaço, Mariana Schmutz, Mélanie Som, Claudia Borchard, Gerrit Wick, Peter Borges, Olga Front Bioeng Biotechnol Bioengineering and Biotechnology Nanoparticles (NPs) assumed an important role in the area of drug delivery. Despite the number of studies including NPs are growing over the last years, their side effects on the immune system are often ignored or omitted. One of the most studied polymers in the nano based drug delivery system field is chitosan (Chit). In the scientific literature, although the physicochemical properties [molecular weight (MW) or deacetylation degree (DDA)] of the chitosan, endotoxin contamination and appropriate testing controls are rarely reported, they can strongly influence immunotoxicity results. The present work aimed to study the immunotoxicity of NPs produced with different DDA and MW Chit polymers and to benchmark it against the polymer itself. Chit NPs were prepared based on the ionic gelation of Chit with sodium tripolyphosphate (TPP). This method allowed the production of two different NPs: Chit 80% NPs (80% DDA) and Chit 93% NPs (93% DDA). In general, we found greater reduction in cell viability induced by Chit NPs than the respective Chit polymers when tested in vitro using human peripheral blood monocytes (PBMCs) or RAW 264.7 cell line. In addition, Chit 80% NPs were more cytotoxic for PBMCs, increased reactive oxygen species (ROS) production (above 156 μg/mL) in the RAW 264.7 cell line and interfered with the intrinsic pathway of coagulation (at 1 mg/mL) when compared to Chit 93% NPs. On the other hand, only Chit 93% NPs induced platelet aggregation (at 2 mg/mL). Although Chit NPs and Chit polymers did not stimulate the nitric oxide (NO) production in RAW 264.7 cells, they induced a decrease in lipopolysaccharide (LPS)-induced NO production at all tested concentrations. None of Chit NPs and polymers caused hemolysis, nor induced PBMCs to secrete TNF-α and IL-6 cytokines. From the obtained results we concluded that the DDA of the Chit polymer and the size of Chit NPs influence the in vitro immunotoxicity results. As the NPs are more cytotoxic than the corresponding polymers, one should be careful in the extrapolation of trends from the polymer to the NPs, and in the comparisons among delivery systems prepared with different DDA chitosans. Frontiers Media S.A. 2020-02-21 /pmc/articles/PMC7047933/ /pubmed/32154232 http://dx.doi.org/10.3389/fbioe.2020.00100 Text en Copyright © 2020 Jesus, Marques, Duarte, Soares, Costa, Colaço, Schmutz, Som, Borchard, Wick and Borges. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Jesus, Sandra
Marques, Ana Patrícia
Duarte, Alana
Soares, Edna
Costa, João Panão
Colaço, Mariana
Schmutz, Mélanie
Som, Claudia
Borchard, Gerrit
Wick, Peter
Borges, Olga
Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility
title Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility
title_full Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility
title_fullStr Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility
title_full_unstemmed Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility
title_short Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility
title_sort chitosan nanoparticles: shedding light on immunotoxicity and hemocompatibility
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047933/
https://www.ncbi.nlm.nih.gov/pubmed/32154232
http://dx.doi.org/10.3389/fbioe.2020.00100
work_keys_str_mv AT jesussandra chitosannanoparticlessheddinglightonimmunotoxicityandhemocompatibility
AT marquesanapatricia chitosannanoparticlessheddinglightonimmunotoxicityandhemocompatibility
AT duartealana chitosannanoparticlessheddinglightonimmunotoxicityandhemocompatibility
AT soaresedna chitosannanoparticlessheddinglightonimmunotoxicityandhemocompatibility
AT costajoaopanao chitosannanoparticlessheddinglightonimmunotoxicityandhemocompatibility
AT colacomariana chitosannanoparticlessheddinglightonimmunotoxicityandhemocompatibility
AT schmutzmelanie chitosannanoparticlessheddinglightonimmunotoxicityandhemocompatibility
AT somclaudia chitosannanoparticlessheddinglightonimmunotoxicityandhemocompatibility
AT borchardgerrit chitosannanoparticlessheddinglightonimmunotoxicityandhemocompatibility
AT wickpeter chitosannanoparticlessheddinglightonimmunotoxicityandhemocompatibility
AT borgesolga chitosannanoparticlessheddinglightonimmunotoxicityandhemocompatibility